149 related articles for article (PubMed ID: 15162351)
1. Telomerase as an independent prognostic factor in head and neck squamous cell carcinoma.
Liao CT; Tung-Chieh Chang J; Wang HM; Chen IH; Lin CY; Chen TM; Hsieh LL; Cheng AJ
Head Neck; 2004 Jun; 26(6):504-12. PubMed ID: 15162351
[TBL] [Abstract][Full Text] [Related]
2. The prognostic value of telomerase expression in peripheral blood mononuclear cells of head and neck cancer patients.
Lee BJ; Wang SG; Choi JS; Lee JC; Goh EK; Kim MG
Am J Clin Oncol; 2006 Apr; 29(2):163-7. PubMed ID: 16601436
[TBL] [Abstract][Full Text] [Related]
3. Telomerase activity in head and neck squamous cell carcinoma and adjacent tissues.
Mao L; El-Naggar AK; Fan YH; Lee JS; Lippman SM; Kayser S; Lotan R; Hong WK
Cancer Res; 1996 Dec; 56(24):5600-4. PubMed ID: 8971162
[TBL] [Abstract][Full Text] [Related]
4. Clinical usefulness of telomerase activation and telomere length in head and neck cancer.
Patel MM; Parekh LJ; Jha FP; Sainger RN; Patel JB; Patel DD; Shah PM; Patel PS
Head Neck; 2002 Dec; 24(12):1060-7. PubMed ID: 12454944
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical determination of the appropriate anti-hTERT antibodies for in situ detection of telomerase activity in frozen sections of head and neck squamous cell carcinomas and tumor margin tissues.
Fabricius EM; Kruse-Boitschenko U; Khoury R; Wildner GP; Raguse JD; Klein M
Int J Oncol; 2009 May; 34(5):1257-79. PubMed ID: 19360339
[TBL] [Abstract][Full Text] [Related]
6. Parotid metastasis--an independent prognostic factor for head and neck cutaneous squamous cell carcinoma.
Ch'ng S; Maitra A; Lea R; Brasch H; Tan ST
J Plast Reconstr Aesthet Surg; 2006; 59(12):1288-93. PubMed ID: 17113505
[TBL] [Abstract][Full Text] [Related]
7. Telomerase activity in oral leukoplakia and head and neck squamous cell carcinoma.
Mutirangura A; Supiyaphun P; Trirekapan S; Sriuranpong V; Sakuntabhai A; Yenrudi S; Voravud N
Cancer Res; 1996 Aug; 56(15):3530-3. PubMed ID: 8758922
[TBL] [Abstract][Full Text] [Related]
8. Prognostic indicators for survival in head and neck squamous cell carcinomas: analysis of a series of 621 cases.
Le Tourneau C; Velten M; Jung GM; Bronner G; Flesch H; Borel C
Head Neck; 2005 Sep; 27(9):801-8. PubMed ID: 16086415
[TBL] [Abstract][Full Text] [Related]
9. [Analysis of risk factors in the prediction of distant metastases of head and neck squamous cell carcinomas].
Li XM; Di B; Shang YD; Zhou YQ; Ma HM; Cheng JM
Zhonghua Er Bi Yan Hou Ke Za Zhi; 2004 Mar; 39(3):171-5. PubMed ID: 15283298
[TBL] [Abstract][Full Text] [Related]
10. Combined evaluation of expression of telomerase, survivin, and anti-apoptotic Bcl-2 family members in relation to loss of differentiation and apoptosis in human head and neck cancers.
Sharma H; Sen S; Mathur M; Bahadur S; Singh N
Head Neck; 2004 Aug; 26(8):733-40. PubMed ID: 15287041
[TBL] [Abstract][Full Text] [Related]
11. Downregulation of TESTIN and its association with cancer history and a tendency toward poor survival in head and neck squamous cell carcinoma.
Gunduz E; Gunduz M; Beder L; Nagatsuka H; Fukushima K; Sutcu R; Delibas N; Yamanaka N; Shimizu K; Nagai N
Arch Otolaryngol Head Neck Surg; 2009 Mar; 135(3):254-60. PubMed ID: 19289703
[TBL] [Abstract][Full Text] [Related]
12. Parotid and cervical nodal status predict prognosis for patients with head and neck metastatic cutaneous squamous cell carcinoma.
Ch'ng S; Maitra A; Allison RS; Chaplin JM; Gregor RT; Lea R; Tan ST
J Surg Oncol; 2008 Aug; 98(2):101-5. PubMed ID: 18523982
[TBL] [Abstract][Full Text] [Related]
13. [Clinicopathologic features and prognostic factors of cervical lymph node metastasis in oral squamous cell carcinoma].
Li XM; DI B; Shang YD; Li J; Cheng JM
Ai Zheng; 2005 Feb; 24(2):208-12. PubMed ID: 15694035
[TBL] [Abstract][Full Text] [Related]
14. The influence of reactivation of the telomerase in tumour tissue on the prognosis of squamous cell carcinomas in the head and neck.
Koscielny S; Eggeling Fv; Dahse R; Fiedler W
J Oral Pathol Med; 2004 Oct; 33(9):538-42. PubMed ID: 15357674
[TBL] [Abstract][Full Text] [Related]
15. Tissue inhibitor of matrix metalloproteinase-1 is prognostic in head and neck squamous cell carcinoma: comparison of the circulating and tissue immunoreactive protein.
Ruokolainen H; Pääkkö P; Turpeenniemi-Hujanen T
Clin Cancer Res; 2005 May; 11(9):3257-64. PubMed ID: 15867221
[TBL] [Abstract][Full Text] [Related]
16. Strong immunohistochemical expression of vascular endothelial growth factor predicts overall survival in head and neck squamous cell carcinoma.
Tse GM; Chan AW; Yu KH; King AD; Wong KT; Chen GG; Tsang RK; Chan AB
Ann Surg Oncol; 2007 Dec; 14(12):3558-65. PubMed ID: 17929099
[TBL] [Abstract][Full Text] [Related]
17. beta-Catenin functions mainly as an adhesion molecule in patients with squamous cell cancer of the head and neck.
Yu Z; Weinberger PM; Provost E; Haffty BG; Sasaki C; Joe J; Camp RL; Rimm DL; Psyrri A
Clin Cancer Res; 2005 Apr; 11(7):2471-7. PubMed ID: 15814622
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathologic risk factors for distant metastases from head and neck squamous cell carcinomas.
Li X; Di B; Shang Y; Zhou Y; Cheng J; He Z
Eur J Surg Oncol; 2009 Dec; 35(12):1348-53. PubMed ID: 19616915
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of mitotic and apoptotic index and the DNA cytometry in head and neck cancer.
Smilek P; Dusek L; Veselý K; Rottenberg J; Kostrica R
Neoplasma; 2005; 52(3):199-207. PubMed ID: 15875080
[TBL] [Abstract][Full Text] [Related]
20. Evidence for lymphangiogenesis and its prognostic implications in head and neck squamous cell carcinoma.
Kyzas PA; Geleff S; Batistatou A; Agnantis NJ; Stefanou D
J Pathol; 2005 Jun; 206(2):170-7. PubMed ID: 15846845
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
